About
Basic Data Updated:
2 months agoThe Corporate was formerly known as Dsm Anti Infectives India Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 170.00 cr and a paid-up capital of Rs 160.30 cr.
The Corporate currently has active open charges totaling ₹200.00 cr.
The Key Managerial Personnel (KMP) at Centrient Pharmaceuticals India Private Limited India are Sumit Agarwal as Company Secretary and Vikram Sehgal as Cfo. Namit Joshi, Devesh Srivastava, and Vikram Sehgal serve as directors at the Company.
Industry
Company Details
- Location
Toansa, Punjab, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
| CIN/LLPIN/FCRN | U24231PB1993PTC023090 |
| Company No. | 023090 |
| Company Classification | Private Limited Indian Non-Government Company |
| Incorporation Date | 19 Jan 1993 |
| Date of AGM | 18 Sep 2023 |
| Date of Balance Sheet | 31 Mar 2023 |
| Listing Status | Unlisted |
| ROC Code | Roc Chandigarh |
Products or Services related to Centrient Pharmaceuticals India Private Limited
Anti Infective API
Financials of Centrient Pharmaceuticals India Private Limited
Centrient Pharmaceuticals India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.46% increase. The company also saw a substantial fall in profitability, with a 31.41% decrease in profit. The company's net worth moved up by a moderate rise of 8.75%.
Corporate Structure
Unlock access to Centrient Pharmaceuticals India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Centrient Pharmaceuticals India Private Limited
Unlock and access historical data on people associated with Centrient Pharmaceuticals India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (2)
SA
Sumit Agarwal Company SecretaryAppointment Date: 17-Dec-2020
Status: Current
VS
Vikram Sehgal CFOAppointment Date: 04-Jun-2021
Status: Current
Board Members(3)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 31 Oct 2018 | ₹200.00 Cr | Open |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Centrient Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Centrient Pharmaceuticals India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Pharmaceuticals Export Promotion Council Of India
Active
20 years 5 months Namit Joshi is a mutual person
Recent activity within the organization
Charges
A charge with Others of Rs. 200.00 cr registered on 31 Oct 2018 with Charge ID 100212988 was modified on 27 Sep 2023.
27 Sep 2023Annual General Meeting
Centrient Pharmaceuticals India Private Limited last Annual general meeting of members was held on 18 Sep 2023 as per latest MCA records.
18 Sep 2023Director Appointment
Devesh Prakash Srivastava was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 01 Apr 2023 & has been associated with this company since 1 year 5 months .
01 Apr 2023Balance Sheet
Centrient Pharmaceuticals India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Chandigarh.
31 Mar 2023Director Appointment
Vikram Aditya Sehgal was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 30 Sep 2021 & has been associated with this company since 2 years 11 months .
30 Sep 2021
Frequently asked questions
What is the Incorporation or founding date of Centrient Pharmaceuticals India Private Limited?
